Article Text

Download PDFPDF
Oral montelukast was better than inhaled salmeterol for reducing exercise induced bronchoconstriction in adults with asthma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

 QUESTION: Is oral montelukast as effective as inhaled salmeterol for prevention of exercise induced bronchoconstriction (EIB) in adults with asthma?


8 week, randomised {allocation concealed*}, blinded {patients, clinicians, outcome assessors, statisticians},* controlled trial.


17 asthma treatment centres in the US.


191 patients who were 15–45 years of age (mean age 26 y, 52% men), had a history of chronic asthma, had an FEV1 ≥65% of the predicted value at rest, and had a decrease in FEV1 ≥20% after a standardised exercise challenge on 2 occasions during baseline measurement. Exclusion criteria were upper respiratory infection or exacerbation of asthma that had required emergency care in the previous month or admission to hospital for asthma in the previous …

View Full Text


  • Source of funding: Merck and Company, Inc.

  • For correspondence: Dr J M Edelman, Merck and Company, Inc., Box 4, HM-220, West Point, PA 19486, USA. Fax +1 215 328 2444.

  • * See glossary.

  • Data provided by author.